PharmaShots | Incisive News in 3 Shots

Subscribe Now

Checkpoint

Checkpoint Reports the US FDA Acceptance of BLA for Cosibelimab to Treat Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Checkpoint Reports the US FDA Acceptance of BLA for Cosibelimab to Treat Metastatic or Locally Advanced Cutaneous Squamous Cell Ca...

March 3, 2023

Checkpoint Reports the Initiation of P-III (CONTERNO) Trial for Cosibelimab as 1L Treatment of Non-Squamous NSCLC

Checkpoint Reports the Initiation of P-III (CONTERNO) Trial for Cosibelimab as 1L Treatment of Non-Squamous NSCLC

December 9, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us